By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) 

11975 El Camino Real, Suite 101

San Diego  California  92130  U.S.A.
Phone: 858-792-6300 Fax: n/a


MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The Company's portfolio of drug candidates includes Pracinostat, a potential best-in-class, oral HDAC inhibitor currently in Phase II clinical studies for advanced hematologic diseases. The Company is also developing ME-344, a novel mitochondrial inhibitor that has shown evidence of clinical activity in refractory solid tumors, and ME-401 (formerly PWT143), a highly selective, oral PI3K delta inhibitor. For more information, please visit




CEO: Daniel Gold, PhD


Please click here for clinical trial information.


Please click here for Mei Pharma job opportunities.

Key Statistics

Ownership: Subsidiary

Web Site: MEI Pharma
Symbol: MEIP


Company News
MEI Pharma (MEIP) Announces Appointment Of Brian Drazba As Chief Financial Officer 4/3/2017 8:06:07 AM
MEI Pharma (MEIP) Reports Second Quarter Fiscal Year 2017 Results 2/8/2017 10:48:57 AM
Helsinn And MEI Pharma (MEIP) Report Prolongation Of Survival Results From Phase 2 Clinical Study Of Pracinostat And Azacitidine In Acute Myeloid Leukemia 12/5/2016 6:43:05 AM
MEI Pharma (MEIP) Reports First Quarter Fiscal Year 2017 Results 11/10/2016 4:07:58 PM
Helsinn And MEI Pharma (MEIP) Announce Long-Term Survival And Response Data From Phase II Clinical Study Of Pracinostat In Acute Myeloid Leukemia Accepted For Oral Presentation At Upcoming American Society of Hematology Annual Meeting 11/3/2016 7:52:17 AM
MEI Pharma (MEIP) Reports Fiscal Year 2016 Results 9/6/2016 10:06:14 AM
MEI Pharma (MSHL) To Present At Wedbush PacGrow Healthcare Conference 8/10/2016 10:50:01 AM
San Diego's MEI Pharma (MEIP) Bags Cancer Deal Worth $464 Million With Helsinn 8/8/2016 6:16:47 AM
MEI Pharma (MSHL)'s Pracinostat Called a Breakthrough By the FDA 8/1/2016 8:13:14 AM
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) To Present At Needham Healthcare Conference 4/5/2016 7:49:09 AM